Clinical Trials
15 trialsNCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
NCT06236061 2026-01-13
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Novartis
Phase 3 Completed
NCT07247162 2025-12-10
LINC CARE
RECORDATI GROUP
Phase 4 Not yet recruiting
NCT04308590 2025-09-04
GRADIENT
Corcept Therapeutics
Phase 3 Completed
NCT03697109 2025-07-16
GRACE
Corcept Therapeutics
Phase 3 Completed
NCT05286632 2024-11-06
KidneYou - Innovative Digital Therapy
Advice Pharma Group srl
Phase NA Completed
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT06256172 2024-02-13
Medlink
Olawuyi Racett Nigeria Ltd
Phase NA Completed
NCT05645653 2022-12-09
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
Hamad Medical Corporation
Phase NA Unknown
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT00392262 2016-11-18
A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
Novartis
Phase 3 Completed
NCT02222480 2016-07-01
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide
Boryung Pharmaceutical Co., Ltd
Phase 2 Completed
NCT01151410 2016-03-07
An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Novartis
Phase 3 Completed
NCT02072330 2014-02-26
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
Takeda
Phase 2/3 Completed
NCT00264004 2012-08-29
Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours
AstraZeneca
Phase 2 Completed